A detailed history of Girard Partners Ltd. transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Girard Partners Ltd. holds 1,662 shares of DGX stock, worth $227,843. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,662
Previous 2,532 34.36%
Holding current value
$227,843
Previous $337,000 32.64%
% of portfolio
0.02%
Previous 0.03%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$125.91 - $144.34 $109,541 - $125,575
-870 Reduced 34.36%
1,662 $227,000
Q1 2024

May 13, 2024

SELL
$123.78 - $142.11 $63,375 - $72,760
-512 Reduced 16.82%
2,532 $337,000
Q4 2023

Feb 09, 2024

SELL
$120.62 - $141.12 $257,282 - $301,008
-2,133 Reduced 41.2%
3,044 $419,000
Q3 2023

Nov 02, 2023

SELL
$121.86 - $144.92 $285,030 - $338,967
-2,339 Reduced 31.12%
5,177 $630,000
Q2 2023

Aug 15, 2023

SELL
$130.56 - $146.84 $1.7 Million - $1.91 Million
-13,034 Reduced 63.43%
7,516 $1.06 Million
Q1 2023

May 12, 2023

SELL
$131.53 - $155.76 $599,382 - $709,798
-4,557 Reduced 18.15%
20,550 $2.91 Million
Q4 2022

Jan 26, 2023

SELL
$123.31 - $157.26 $73,246 - $93,412
-594 Reduced 2.31%
25,107 $0
Q3 2022

Oct 20, 2022

SELL
$121.77 - $141.1 $183,020 - $212,073
-1,503 Reduced 5.52%
25,701 $3.15 Million
Q2 2022

Jul 26, 2022

SELL
$127.07 - $145.39 $239,908 - $274,496
-1,888 Reduced 6.49%
27,204 $3.62 Million
Q1 2022

Apr 27, 2022

SELL
$129.09 - $164.35 $1.44 Million - $1.84 Million
-11,185 Reduced 27.77%
29,092 $3.98 Million
Q4 2021

Feb 02, 2022

SELL
$140.36 - $173.01 $102,041 - $125,778
-727 Reduced 1.77%
40,277 $6.97 Million
Q3 2021

Nov 01, 2021

SELL
$132.95 - $158.0 $4.61 Million - $5.47 Million
-34,640 Reduced 85.32%
5,958 $5.96 Million
Q3 2021

Nov 01, 2021

BUY
$132.95 - $158.0 $4.66 Million - $5.54 Million
35,046 Added 588.22%
41,004 $5.96 Million
Q2 2021

Aug 10, 2021

BUY
$126.66 - $141.48 $215,575 - $240,798
1,702 Added 4.38%
40,598 $5.36 Million
Q1 2021

May 06, 2021

BUY
$114.63 - $133.34 $205,875 - $239,478
1,796 Added 4.84%
38,896 $4.99 Million
Q4 2020

Feb 02, 2021

BUY
$112.7 - $128.05 $161,724 - $183,751
1,435 Added 4.02%
37,100 $4.42 Million
Q3 2020

Nov 13, 2020

BUY
$107.05 - $130.01 $713,488 - $866,516
6,665 Added 22.98%
35,665 $4.08 Million
Q2 2020

Aug 10, 2020

SELL
$73.34 - $122.61 $49,284 - $82,393
-672 Reduced 2.26%
29,000 $3.3 Million
Q1 2020

May 01, 2020

BUY
$75.14 - $115.68 $216,628 - $333,505
2,883 Added 10.76%
29,672 $2.38 Million
Q4 2019

Feb 03, 2020

BUY
$100.29 - $107.99 $79,529 - $85,636
793 Added 3.05%
26,789 $2.86 Million
Q3 2019

Nov 01, 2019

BUY
$97.85 - $107.42 $68,788 - $75,516
703 Added 2.78%
25,996 $2.78 Million
Q2 2019

Aug 12, 2019

BUY
$85.18 - $101.94 $74,958 - $89,707
880 Added 3.6%
25,293 $2.58 Million
Q1 2019

May 08, 2019

BUY
$80.68 - $89.92 $710,952 - $792,375
8,812 Added 56.48%
24,413 $2.2 Million
Q4 2018

Feb 11, 2019

BUY
$79.75 - $108.38 $176,327 - $239,628
2,211 Added 16.51%
15,601 $1.3 Million
Q3 2018

Nov 09, 2018

BUY
$105.42 - $114.99 $453,306 - $494,457
4,300 Added 47.3%
13,390 $1.44 Million
Q2 2018

Aug 07, 2018

BUY
$97.35 - $113.14 $884,911 - $1.03 Million
9,090 New
9,090 $999,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Girard Partners Ltd. Portfolio

Follow Girard Partners Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Girard Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Girard Partners Ltd. with notifications on news.